Page last updated: 2024-10-22

ag-1296 and Glioblastoma

ag-1296 has been researched along with Glioblastoma in 2 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sciaccaluga, M1
D'Alessandro, G1
Pagani, F1
Ferrara, G1
Lopez, N1
Warr, T1
Gorello, P1
Porzia, A1
Mainiero, F1
Santoro, A1
Esposito, V1
Cantore, G1
Castigli, E1
Limatola, C1
Watanabe, T1
Ohtani, T1
Aihara, M1
Ishiuchi, S1

Other Studies

2 other studies available for ag-1296 and Glioblastoma

ArticleYear
Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Cell Line, Tumor; Chemotaxis; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Receptor

2013
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
    Journal of neurosurgery, 2013, Volume: 118, Issue:4

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Model

2013